Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2017-09-17 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
关于全资子公司签订国有建设用地使用权出让合同的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the signing of a land use rights transfer contract by a wholly-owned subsidiary of the company. It details the transaction background, contract terms, and potential risks related to the land acquisition for an industrial project. There are no financial statements, earnings data, or detailed management analysis. The document is a formal disclosure of a specific transaction and does not constitute a full financial report or regulatory certification. It is not a report publication announcement since it contains substantive transaction details rather than just a notice of report availability. Therefore, it fits best under the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2017-09-17 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by Chengdu Berry Genomics Co., Ltd. It details the unusual price movements of the company's stock over three trading days, the company's investigation into the cause, confirmation of no undisclosed material information, and a risk warning to investors. There are no financial statements, no report attachments, no management discussion of financial results, and no mention of annual or quarterly reports. The document is a regulatory announcement related to stock price behavior and compliance with disclosure rules, typical of a Regulatory Filings (RNS) category. The document length is short (1737 characters), and it is not a report publication announcement or certification letter. Therefore, the best classification is Regulatory Filings (RNS).
2017-09-14 Chinese
关于控股子公司完成工商注册登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration for a controlling subsidiary of the company. It provides details about the subsidiary's registration, legal representative, capital, business scope, and information about the cooperating partner company. There is no financial data, no mention of financial results, no discussion of management changes, no voting results, and no regulatory certifications. The document is a formal announcement of a corporate event (subsidiary registration) rather than a financial report or regulatory filing. It is also relatively short (1629 characters) and does not indicate it is a report or presentation. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other categories.
2017-09-12 Chinese
关于全资子公司完成工商注册登记的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the completion of business registration for a wholly-owned subsidiary. It references prior shareholder meeting resolutions and provides details about the new subsidiary's registration, legal representative, capital, and business scope. The document is short (971 characters) and serves as a formal public notice of a corporate event rather than a financial report or detailed filing. It does not contain financial statements, audit information, or management discussion. It is not a report publication announcement since it does not mention the release or availability of a report. The content fits best with a Regulatory Filing (RNS) as it is a general corporate announcement that does not fit other specific categories like MANG (management changes) or CAP (capital updates).
2017-08-31 Chinese
2017前三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the first three quarters of 2017, including estimated net profit and earnings per share, with a note that the forecast has not been audited. It mentions that detailed financial data will be disclosed in the third quarter report. The document is relatively short (1432 characters) and serves as an earnings preview rather than a full financial report. It does not contain actual financial statements or detailed analysis, only projections and explanations of changes. Therefore, it fits the category of an Earnings Release (ER), which is an initial announcement of quarterly/periodical financial results with key highlights only. 9M 2017
2017-08-30 Chinese
2017年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "成都市贝瑞和康基因技术股份有限公司 2017 年半年度报告全文" which translates to "Berry Genomics Co., Ltd 2017 Semi-Annual Report Full Text." It contains detailed financial data, business overview, management discussion and analysis, financial statements, and other comprehensive information typical of an interim or quarterly report. The report period is clearly stated as January 1, 2017 to June 30, 2017, confirming it covers a half-year period. The document is lengthy (15,000 characters) and includes substantive financial data and analysis, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2017
2017-08-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.